MODULATEURS D'ARN ACTIVATEUR DE KLK3
- 专利权人:
- Inc.;Ionis Pharmaceuticals
- 发明人:
- 申请号：
- EP17753791.7
- 公开号：
- EP3417064A4
- 申请日:
- 2017.02.16
- 申请国别(地区):
- EP
- 年份:
- 2019
- 代理人:
- 摘要：
- The present embodiments provide methods, compounds, and compositions useful for inhibiting KLK3 eRNA expression, which may be useful for treating, preventing, or ameliorating cancer, such as prostate cancer.
- 来源网站：
- 中国工程科技知识中心
